ERBB3 and head and neck squamous cell carcinoma: HER2 and HER3 levels are elevated upon EGFR inhibitor treatment, and the HER2/HER3 heterodimer is involved in IKK/NF-κB signal up-regulation by EGFR inhibitors in HNSCC cells